The PCAI Difference

With medical mushrooms and medical cannabis being federally legal in Jamaica, it was chosen as the ideal location for our company to perform basic science and clinical research and development.

In association with our Jamaican licensed medical cannabis partner, Apollon Formularies Jamaica, Ltd., PCAI is fully positioned to perform discovery to develop combinatorial pharmaceutical, nutraceutical, and cosmeceutical products using both cannabis and psilocybin based products in one of the rare countries in the world where this type of discovery is federally legal.

Combining a world-class science team, a Jamaican medical team of licensed and experienced physicians, world-renowned experts in artificial intelligence and laboratory medicine, a fully-licensed medical cannabis company partner, indigenous healing plants and a legal environment to research, develop, commercialize products and treat patients with medical cannabis and medical mushrooms (Psilocybin), PCAI has a very rare opportunity and significant head start to create a large global intellectual property portfolio comprising seminal blocking patents in one of the few places in the world where this is possible. 

Artificial Intelligence and Machine Learning

PCAI uses state-of-the-art laboratory medicine and machine learning (AI) techniques with a world-renowned team of experts in the field to create a full line of patient-specific medical mushroom and medical cannabis combination designer extracts. 

• Analyze mushroom genetics, phenotypes and biochemistry with PCAI proprietary AI techniques

• Utilize AI-driven results to create disease-specific patentable medical mushroom treatments (designer extracts)

PCAI: Jamaica